Plasma Is the New Risk Factor

Premium

It may not be right around the corner, but a biomarker test for increased susceptibility to Alzheimer's disease might be waiting down the road. In a recent study, researchers at the Mayo Clinic Jacksonville found that blood levels of amyloid beta proteins were higher in young relatives of patients with late onset Alzheimer's disease than in non-relative controls, which suggests that genetic factors controlling the Aβ proteins — including the APOE4 genetic variant, a well known risk factor — are related to higher risk of developing the disease.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.